Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lower Acetaminophen Doses Recommended Despite Cost Impact, Lack Of Data

This article was originally published in The Tan Sheet

Executive Summary

A joint advisory committee recommended as a "top priority" that FDA lower the maximum single and daily dose of acetaminophen, despite inconclusive data that the current dose poses significant hepatotoxicity risks

Related Content

McNeil Lowers Recommended Maximum Dose For Extra Strength Tylenol
Acetaminophen Panel To Mull Expanded Dosing, Standard Solid Concentration
OTC Industry Standardizes Pediatric Liquid Acetaminophen Concentration
Glaxo Acetaminophen Efficacy Studies Fill FDA's 1,000-MG Dose Data Gaps
FDA Advisory Panel To Evaluate Acetaminophen Pediatric Dosing
In Brief
NDAC Veterans Join DSaRM Advisory Panel For DXM Safety Meeting
Wolfe Absence May Have Disarming Effect On DXM Safety Panel
FDA Agenda Pushes Back Sunscreen Rule, Cough/Cold Dosing Proposal
Pharma Firms Stir OTC Market, FDA Hones Enforcement: Top Stories Of 2009





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts